Show
Sort by
-
Development of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB<sub>1</sub>R) “Cis-On” Agonist
-
A new cannabinoid receptor 1 selective agonist evading the 2021 “China ban”: ADB‐FUBIATA
-
Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists
-
Cov²MS: An Automated and Quantitative Matrix-Independent Assay for Mass Spectrometric Measurement of SARS-CoV-2 Nucleocapsid Protein
-
A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs
-
- Journal Article
- A1
- open access
Machine learning to assist in large-scale, activity-based synthetic cannabinoid receptor agonist screening of serum samples
-
The rise and fall of isotonitazene and brorphine : two recent stars in the synthetic opioid firmament
-
Volumetric absorptive microsampling as a suitable tool to monitor tyrosine kinase inhibitors
-
- Journal Article
- A1
- open access
Promising tools to facilitate the implementation of TDM of biologics in clinical practice
-
Phenethyl-4-ANPP : a marginally active byproduct suggesting a switch in illicit fentanyl synthesis routes